We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

2,365 hedge funds and large institutions have $173B invested in Thermo Fisher Scientific in 2023 Q3 according to their latest regulatory filings, with 141 funds opening new positions, 967 increasing their positions, 887 reducing their positions, and 135 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more repeat investments, than reductions

Existing positions increased: 967 | Existing positions reduced: 887

4% more first-time investments, than exits

New positions opened: 141 | Existing positions closed: 135

0.89% less ownership

Funds ownership: 89.44%88.54% (-0.89%)

1% less funds holding

Funds holding: 2,3882,365 (-23)

2% less call options, than puts

Call options by funds: $1.23B | Put options by funds: $1.25B

3% less capital invested

Capital invested by funds: $178B → $173B (-$4.73B)

1% less funds holding in top 10

Funds holding in top 10: 141139 (-2)

Holders
2,365
Holders Change
-23
Holders Change %
-0.96%
% of All Funds
37.53%
Holding in Top 10
139
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-1.42%
% of All Funds
2.21%
New
141
Increased
967
Reduced
887
Closed
135
Calls
$1.23B
Puts
$1.25B
Net Calls
-$26.6M
Net Calls Change
+$128M
Name Holding Trade Value Shares
Change
Change in
Stake
TRCT
676
Tower Research Capital (TRC)
New York
$7.81M +$4.85M +9,098 +144%
KWM
677
Kingsview Wealth Management
Oregon
$7.8M +$234K +440 +3%
WC
678
Woodstock Corp
Massachusetts
$7.76M +$1.07K +2 +0%
PHP
679
Parkman Healthcare Partners
Connecticut
$7.76M +$8.17M +15,332 New
AHC
680
Adell Harriman & Carpenter
Texas
$7.72M -$121K -227 -1%
BAM
681
Bell Asset Management
Australia
$7.72M +$1.74M +3,268 +27%
JCM
682
Jag Capital Management
Missouri
$7.67M -$557K -1,045 -6%
FNT
683
First National Trust
Pennsylvania
$7.66M -$119K -223 -1%
SF
684
Synovus Financial
Georgia
$7.6M -$1.78M -3,340 -18%
SRC
685
Stone Run Capital
New York
$7.6M +$13.3K +25 +0.2%
NB
686
Norinchukin Bank
Japan
$7.59M -$9.32M -17,495 -54%
SG Americas Securities
687
SG Americas Securities
New York
$7.59M -$2.5M -4,690 -24%
LGF
688
LGT Group Foundation
Liechtenstein
$7.54M -$197K -369 -2%
AMI
689
Amica Mutual Insurance
Rhode Island
$7.46M
AI
690
ArchPoint Investors
Florida
$7.44M
GH
691
GAM Holding
Switzerland
$7.41M -$1.6K -3 -0%
JGUA
692
John G. Ullman & Associates
New York
$7.4M -$133K -250 -2%
KRSITF
693
Kentucky Retirement Systems Insurance Trust Fund
Kentucky
$7.34M +$350K +657 +5%
CWM
694
Curi Wealth Management
North Carolina
$7.33M -$233K -437 -3%
MPM
695
MBB Public Markets
Illinois
$7.32M +$373K +700 +5%
GCA
696
Greenwood Capital Associates
South Carolina
$7.27M -$58.6K -110 -0.8%
MCM
697
Mitchell Capital Management
Kansas
$7.26M -$17.6K -33 -0.2%
FCBT
698
First Citizens Bank & Trust
North Carolina
$7.25M -$549K -1,030 -7%
MCP
699
Mirador Capital Partners
California
$7.24M +$91.7K +172 +1%
CIG
700
Consolidated Investment Group
Colorado
$7.24M

TMO Hedge Fund Activity: Q3 2023 in Review

2,365 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2023, worth a combined $173B — down 2.7% from $178B a quarter earlier.

Buyers outnumbered sellers: 141 funds opened new TMO positions and 135 closed out — a net gain of 6 holders — while 967 added to existing stakes and 887 trimmed.

The largest buyer was DZ Bank, adding an estimated $755M. The largest seller was Arthur M. Cohen & Associates, cutting an estimated $1.66B.

  • 2,365 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2023, down from 2,388 in Q2 2023.
  • Funds reported $173B of Thermo Fisher Scientific stock for Q3 2023, down 2.7% quarter-over-quarter.
  • 141 funds opened new Thermo Fisher Scientific positions in Q3 2023 and 135 closed out, a net change of +6 holders.
  • The largest Thermo Fisher Scientific buyer in Q3 2023 was DZ Bank, an estimated $755M added.
  • The largest Thermo Fisher Scientific seller in Q3 2023 was Arthur M. Cohen & Associates, an estimated $1.66B sold.

Based on aggregated 13F filings for Q3 2023.